<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4368781</article-id><article-id pub-id-type="pmid">25793373</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0117639</article-id><article-id pub-id-type="publisher-id">PONE-D-14-30874</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The 12p13.33/<italic>RAD52</italic> Locus and Genetic Susceptibility to Squamous Cell Cancers of Upper Aerodigestive Tract</article-title><alt-title alt-title-type="running-head"><italic>RAD52</italic> and Upper Aerodigestive Tract Cancer</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Delahaye-Sourdeix</surname><given-names>Manon</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oliver</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Timofeeva</surname><given-names>Maria N.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gaborieau</surname><given-names>Val&#x000e9;rie</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Johansson</surname><given-names>Mattias</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chabrier</surname><given-names>Am&#x000e9;lie</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wozniak</surname><given-names>Magdalena B.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Brenner</surname><given-names>Darren R.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vall&#x000e9;e</surname><given-names>Maxime P.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Anantharaman</surname><given-names>Devasena</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lagiou</surname><given-names>Pagona</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Holc&#x000e1;tov&#x000e1;</surname><given-names>Ivana</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Richiardi</surname><given-names>Lorenzo</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kjaerheim</surname><given-names>Kristina</given-names></name><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Agudo</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Castellsagu&#x000e9;</surname><given-names>Xavier</given-names></name><xref ref-type="aff" rid="aff008"><sup>8</sup></xref><xref ref-type="aff" rid="aff009"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Macfarlane</surname><given-names>Tatiana V.</given-names></name><xref ref-type="aff" rid="aff010"><sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Barzan</surname><given-names>Luigi</given-names></name><xref ref-type="aff" rid="aff011"><sup>11</sup></xref></contrib><contrib contrib-type="author"><name><surname>Canova</surname><given-names>Cristina</given-names></name><xref ref-type="aff" rid="aff012"><sup>12</sup></xref><xref ref-type="aff" rid="aff013"><sup>13</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thakker</surname><given-names>Nalin S.</given-names></name><xref ref-type="aff" rid="aff014"><sup>14</sup></xref></contrib><contrib contrib-type="author"><name><surname>Conway</surname><given-names>David I.</given-names></name><xref ref-type="aff" rid="aff015"><sup>15</sup></xref></contrib><contrib contrib-type="author"><name><surname>Znaor</surname><given-names>Ariana</given-names></name><xref ref-type="aff" rid="aff016"><sup>16</sup></xref></contrib><contrib contrib-type="author"><name><surname>Healy</surname><given-names>Claire M.</given-names></name><xref ref-type="aff" rid="aff017"><sup>17</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ahrens</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="aff018"><sup>18</sup></xref><xref ref-type="aff" rid="aff019"><sup>19</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zaridze</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff020"><sup>20</sup></xref></contrib><contrib contrib-type="author"><name><surname>Szeszenia-Dabrowska</surname><given-names>Neonilia</given-names></name><xref ref-type="aff" rid="aff021"><sup>21</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lissowska</surname><given-names>Jolanta</given-names></name><xref ref-type="aff" rid="aff022"><sup>22</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fabianova</surname><given-names>Eleonora</given-names></name><xref ref-type="aff" rid="aff023"><sup>23</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mates</surname><given-names>Ioan Nicolae</given-names></name><xref ref-type="aff" rid="aff024"><sup>24</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bencko</surname><given-names>Vladimir</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Foretova</surname><given-names>Lenka</given-names></name><xref ref-type="aff" rid="aff025"><sup>25</sup></xref></contrib><contrib contrib-type="author"><name><surname>Janout</surname><given-names>Vladimir</given-names></name><xref ref-type="aff" rid="aff026"><sup>26</sup></xref></contrib><contrib contrib-type="author"><name><surname>Curado</surname><given-names>Maria Paula</given-names></name><xref ref-type="aff" rid="aff027"><sup>27</sup></xref></contrib><contrib contrib-type="author"><name><surname>Koifman</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="aff028"><sup>28</sup></xref></contrib><contrib contrib-type="author"><name><surname>Menezes</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff029"><sup>29</sup></xref></contrib><contrib contrib-type="author"><name><surname>W&#x000fc;nsch-Filho</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="aff030"><sup>30</sup></xref></contrib><contrib contrib-type="author"><name><surname>Eluf-Neto</surname><given-names>Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="aff030"><sup>30</sup></xref></contrib><contrib contrib-type="author"><name><surname>Boffetta</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff031"><sup>31</sup></xref></contrib><contrib contrib-type="author"><name><surname>Garrote</surname><given-names>Leticia Fern&#x000e1;ndez</given-names></name><xref ref-type="aff" rid="aff032"><sup>32</sup></xref></contrib><contrib contrib-type="author"><name><surname>Serraino</surname><given-names>Diego</given-names></name><xref ref-type="aff" rid="aff033"><sup>33</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lener</surname><given-names>Marcin</given-names></name><xref ref-type="aff" rid="aff034"><sup>34</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jaworowska</surname><given-names>Ewa</given-names></name><xref ref-type="aff" rid="aff035"><sup>35</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lubi&#x00144;ski</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff034"><sup>34</sup></xref></contrib><contrib contrib-type="author"><name><surname>Boccia</surname><given-names>Stefania</given-names></name><xref ref-type="aff" rid="aff036"><sup>36</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rajkumar</surname><given-names>Thangarajan</given-names></name><xref ref-type="aff" rid="aff037"><sup>37</sup></xref></contrib><contrib contrib-type="author"><name><surname>Samant</surname><given-names>Tanuja A.</given-names></name><xref ref-type="aff" rid="aff038"><sup>38</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mahimkar</surname><given-names>Manoj B.</given-names></name><xref ref-type="aff" rid="aff038"><sup>38</sup></xref></contrib><contrib contrib-type="author"><name><surname>Matsuo</surname><given-names>Keitaro</given-names></name><xref ref-type="aff" rid="aff039"><sup>39</sup></xref></contrib><contrib contrib-type="author"><name><surname>Franceschi</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="aff040"><sup>40</sup></xref></contrib><contrib contrib-type="author"><name><surname>Byrnes</surname><given-names>Graham</given-names></name><xref ref-type="aff" rid="aff041"><sup>41</sup></xref></contrib><contrib contrib-type="author"><name><surname>Brennan</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>McKay</surname><given-names>James D.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Genetic Cancer Susceptibility group (GCS), International Agency for Research on Cancer (IARC), Lyon, France</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Genetic Epidemiology group (GEP), International Agency for Research on Cancer (IARC), Lyon, France</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, United Kingdom</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Department of Hygiene, Epidemiology and Medical Statistics, University of Athens School of Medicine, Athens, Greece</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic</addr-line></aff><aff id="aff006"><label>6</label><addr-line>University of Turin, Department of Medical Sciences, Unit of Cancer Epidemiology, Turin, Italy</addr-line></aff><aff id="aff007"><label>7</label><addr-line>Cancer Registry of Norway, Oslo, Norway</addr-line></aff><aff id="aff008"><label>8</label><addr-line>Catalan Institute of Oncology-ICO, IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain</addr-line></aff><aff id="aff009"><label>9</label><addr-line>CIBER Epidemiolog&#x000ed;a y Salud P&#x000fa;blica (CIBERESP), Madrid, Spain</addr-line></aff><aff id="aff010"><label>10</label><addr-line>School of Medicine and Dentistry, University of Aberdeen, Aberdeen, United Kingdom</addr-line></aff><aff id="aff011"><label>11</label><addr-line>General Hospital of Pordenone, Pordenone, Italy</addr-line></aff><aff id="aff012"><label>12</label><addr-line>Department of Environmental Medicine and Public Health, University of Padova, Padova, Italy</addr-line></aff><aff id="aff013"><label>13</label><addr-line>MRC-HPA Centre for Environment and Health, Respiratory Epidemiology and Public Health, National Heart and Lung Institute, Imperial College, London, United Kingdom</addr-line></aff><aff id="aff014"><label>14</label><addr-line>University of Manchester, School of Dentistry, Manchester, United Kingdom</addr-line></aff><aff id="aff015"><label>15</label><addr-line>University of Glasgow Dental School, Glasgow, Scotland, United Kingdom</addr-line></aff><aff id="aff016"><label>16</label><addr-line>Croatian National Cancer Registry, Croatian National Institute of Public Health, Zagreb, Croatia</addr-line></aff><aff id="aff017"><label>17</label><addr-line>Trinity College School of Dental Science, Dublin, Ireland</addr-line></aff><aff id="aff018"><label>18</label><addr-line>Leibniz Institute for Prevention Research and Epidemiology&#x02014;BIPS, Bremen, Germany</addr-line></aff><aff id="aff019"><label>19</label><addr-line>Faculty of Mathematics and Computer Science, University of Bremen, Bremen, Germany</addr-line></aff><aff id="aff020"><label>20</label><addr-line>Institute of Carcinogenesis, Cancer Research Centre, Moscow, Russian Federation</addr-line></aff><aff id="aff021"><label>21</label><addr-line>Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland</addr-line></aff><aff id="aff022"><label>22</label><addr-line>Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland</addr-line></aff><aff id="aff023"><label>23</label><addr-line>Regional Authority of Public Health, Banska Bystrica, Slovakia</addr-line></aff><aff id="aff024"><label>24</label><addr-line>Saint Mary General and Esophageal Surgery Clinic, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania</addr-line></aff><aff id="aff025"><label>25</label><addr-line>Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic</addr-line></aff><aff id="aff026"><label>26</label><addr-line>Palacky University, Olomouc, Czech Republic</addr-line></aff><aff id="aff027"><label>27</label><addr-line>International Prevention Research Institute (IPRI), Ecully, France</addr-line></aff><aff id="aff028"><label>28</label><addr-line>National School of Public Health/FIOCRUZ, Rio de Janeiro, Brazil</addr-line></aff><aff id="aff029"><label>29</label><addr-line>Universidade Federal de Pelotas, Pelotas, Brazil</addr-line></aff><aff id="aff030"><label>30</label><addr-line>Universidade de Sao Paulo, Sao Paulo, Brazil</addr-line></aff><aff id="aff031"><label>31</label><addr-line>The Tisch Cancer Institute Mount Sinai School of Medicine, New York, NY, United States of America</addr-line></aff><aff id="aff032"><label>32</label><addr-line>Institute of Oncology and Radiobiology, Havana, Cuba</addr-line></aff><aff id="aff033"><label>33</label><addr-line>Centro di Riferimento Oncologico, IRCSS, Unit of Epidemiology and Biostatistics, Aviano, Italy</addr-line></aff><aff id="aff034"><label>34</label><addr-line>Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland</addr-line></aff><aff id="aff035"><label>35</label><addr-line>Department of Otolaryngology and Laryngological Oncology, Pomeranian Medical University, Szczecin, Poland</addr-line></aff><aff id="aff036"><label>36</label><addr-line>Institute of Public Health, Section of Hygiene, Faculty of Medicine, Universit&#x000e0; Cattolica del Sacro Cuore, Rome, Italy</addr-line></aff><aff id="aff037"><label>37</label><addr-line>Dept. of Molecular Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India</addr-line></aff><aff id="aff038"><label>38</label><addr-line>Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India</addr-line></aff><aff id="aff039"><label>39</label><addr-line>Department of Health Promotion, Division of Oral Pathology, Kyushu Dental University, Kitakyushu, Japan</addr-line></aff><aff id="aff040"><label>40</label><addr-line>Infections and Cancer Epidemiology group (ICE), International Agency for Research on Cancer (IARC), Lyon, France</addr-line></aff><aff id="aff041"><label>41</label><addr-line>Biostatistics group (BST), International Agency for Research on Cancer (IARC), Lyon, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Toland</surname><given-names>Amanda Ewart</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Ohio State University Medical Center, UNITED STATES</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: MDS GB P. Brennan JDM. Performed the experiments: MDS JO AC JDM. Analyzed the data: MDS JO MNT VG MJ MBW DB MPV DA GB. Contributed reagents/materials/analysis tools: PL IH LR KK AA XC TVM LB CC NST DIC AZ CMH WA DZ NSD J. Lissowska EF INM VB LF VJ MPC SK AM VWF JEN P. Boffetta LFG DS ML EJ J. Lubi&#x00144;ski SB TR TAS MBM KM SF. Wrote the paper: MDS JO MNT MJ JDM. Final manuscript writing: MDS JO MNT VG MJ AC MBW DRB MPV DA PL IH LR KK AA XC TVM LB CC NST DIC AZ CMH WA DZ NSD J. Lissowska EF INM VB LF VJ MPC SK AM VWF JEN P. Boffetta LFG DS ML EJ J. Lubi&#x00144;ski SB TR TAS MBM KM SF GB P. Brennan JDM.</p></fn><corresp id="cor001">* E-mail: <email>gcs@iarc.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>3</issue><elocation-id>e0117639</elocation-id><history><date date-type="received"><day>16</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>29</day><month>12</month><year>2014</year></date></history><permissions><copyright-year>2015</copyright-year><copyright-holder>Delahaye-Sourdeix et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0117639.pdf"/><abstract><p>Genetic variants located within the 12p13.33/<italic>RAD52</italic> locus have been associated with lung squamous cell carcinoma (LUSC). Here, within 5,947 UADT cancers and 7,789 controls from 9 different studies, we found rs10849605, a common intronic variant in <italic>RAD52</italic>, to be also associated with upper aerodigestive tract (UADT) squamous cell carcinoma cases (OR = 1.09, 95% CI: 1.04&#x02013;1.15, p = 6x10<sup>&#x02212;4</sup>). We additionally identified rs10849605 as a <italic>RAD52 cis</italic>-eQTL inUADT(p = 1x10<sup>&#x02212;3</sup>) and LUSC (p = 9x10<sup>&#x02212;4</sup>) tumours, with the UADT/LUSC risk allele correlated with increased <italic>RAD52</italic> expression levels. The 12p13.33 locus, encompassing rs10849605/<italic>RAD52</italic>, was identified as a significant somatic focal copy number amplification in UADT(n = 374, q-value = 0.075) and LUSC (n = 464, q-value = 0.007) tumors and correlated with higher <italic>RAD52</italic> tumor expression levels (p = 6x10<sup>&#x02212;48</sup> and p = 3x10<sup>&#x02212;29</sup> in UADT and LUSC, respectively). In combination, these results implicate increased <italic>RAD52</italic> expression in both genetic susceptibility and tumorigenesis of UADT and LUSC tumors.</p></abstract><funding-group><funding-statement>Funding for study coordination, genotyping of replication studies and statistical analysis was provided by the US National Institutes of Health (R01 CA092039 05/05S1) and the National Institute of Dental and Craniofacial Research (1R03DE020116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="1"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Upper aerodigestive tract (UADT) cancers, comprising of the oral cavity, larynx and esophagus, are the fourth most common cause of cancer death worldwide [<xref rid="pone.0117639.ref001" ref-type="bibr">1</xref>]. While consumption of tobacco and alcohol are the main UADT cancers risk factors [<xref rid="pone.0117639.ref002" ref-type="bibr">2</xref>], genetic susceptibility has been hypothesized to play a role in the pathogenesis of this disease [<xref rid="pone.0117639.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0117639.ref004" ref-type="bibr">4</xref>].</p><p>Exposure to tobacco and alcohol leads to cell damage and DNA alterations that, in the absence of appropriate repair, may cause cell cycle deregulation and cancer development [<xref rid="pone.0117639.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0117639.ref006" ref-type="bibr">6</xref>]. Homologous Recombination (HR) is an important manner by which cells repair DNA lesions [<xref rid="pone.0117639.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0117639.ref008" ref-type="bibr">8</xref>]. The <italic>RAD52</italic> gene is involved in the homologous recombination DNA repair process [<xref rid="pone.0117639.ref009" ref-type="bibr">9</xref>] by mediating RAD51, a central HR gene that forms a helical nucleoprotein filament involved in the search for homology and strand pairing [<xref rid="pone.0117639.ref010" ref-type="bibr">10</xref>].</p><p>Genome wide association studies (GWAS) have implicated the rs10849605 genetic variant at 12p13.33, the locus that encompasses <italic>RAD52</italic> in the human genome, to be associated with a modest, but statistically significant, increased risk of lung cancer [<xref rid="pone.0117639.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0117639.ref012" ref-type="bibr">12</xref>]. It appears most relevant to lung squamous cell carcinoma (LUSC) and small cell lung cancers, but with little evidence within lung adenocarcinomas (LUAD) [<xref rid="pone.0117639.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0117639.ref012" ref-type="bibr">12</xref>]. Although the molecular mechanisms contributing to initiation and progression are still poorly understood, squamous cell carcinomas (SCC) of different anatomical sites share many phenotypic and molecular characteristics with each other [<xref rid="pone.0117639.ref013" ref-type="bibr">13</xref>]. The aim of the present study was to investigate <italic>RAD52</italic> in the context of genetic susceptibility to SCC of the UADT, to explore how this association might be mediated and examine the somatic mutation events at the <italic>RAD52</italic> 12p13.33 locus.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Study subjects</title><p>A total of 9 case-control studies of UADT cancer participated in our present study totalling 5,947 UADT cancer cases and 7,789 controls. Study designs and population characteristics have been described in more details previously [<xref rid="pone.0117639.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0117639.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0117639.ref015" ref-type="bibr">15</xref>] and are briefly described in <xref rid="pone.0117639.t001" ref-type="table">Table 1</xref>. In most studies, the control subjects were frequency matched to the cases on age, sex, and additional factors (e.g., study site and hospital). Written informed consent was obtained from all study subjects, and the investigations were approved by the institutional review boards at each study center. Analysis was restricted to squamous cell carcinomas.</p><table-wrap id="pone.0117639.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0117639.t001</object-id><label>Table 1</label><caption><title>Demographic characteristics of the cases and controls included in the genetic susceptibility study of <italic>RAD52</italic>/rs10849605.</title></caption><alternatives><graphic id="pone.0117639.t001g" xlink:href="pone.0117639.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th colspan="2" align="center" rowspan="1">Cases</th><th colspan="2" align="center" rowspan="1">Controls</th><th align="left" rowspan="1" colspan="1">OR</th><th align="left" rowspan="1" colspan="1">95%CI</th><th align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Gender</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">4604</td><td align="left" rowspan="1" colspan="1">77.4</td><td align="left" rowspan="1" colspan="1">5750</td><td align="left" rowspan="1" colspan="1">73.8</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">1343</td><td align="left" rowspan="1" colspan="1">22.6</td><td align="left" rowspan="1" colspan="1">2039</td><td align="left" rowspan="1" colspan="1">26.2</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">(0.70&#x02013;0.83)</td><td align="left" rowspan="1" colspan="1">3.7x10<sup>&#x02212;10</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age group</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003c;50 years old</td><td align="left" rowspan="1" colspan="1">1083</td><td align="left" rowspan="1" colspan="1">18.2</td><td align="left" rowspan="1" colspan="1">1564</td><td align="left" rowspan="1" colspan="1">20.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e; = 50 years old</td><td align="left" rowspan="1" colspan="1">4483</td><td align="left" rowspan="1" colspan="1">75.4</td><td align="left" rowspan="1" colspan="1">6224</td><td align="left" rowspan="1" colspan="1">79.9</td><td align="left" rowspan="1" colspan="1">1.26</td><td align="left" rowspan="1" colspan="1">(1.14&#x02013;1.38)</td><td align="left" rowspan="1" colspan="1">1.6x10<sup>&#x02212;6</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Missing</td><td align="left" rowspan="1" colspan="1">381</td><td align="left" rowspan="1" colspan="1">6.4</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.0</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Smoking status</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Never smokers</td><td align="left" rowspan="1" colspan="1">825</td><td align="left" rowspan="1" colspan="1">13.9</td><td align="left" rowspan="1" colspan="1">2501</td><td align="left" rowspan="1" colspan="1">32.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ever smokers</td><td align="left" rowspan="1" colspan="1">4735</td><td align="left" rowspan="1" colspan="1">79.6</td><td align="left" rowspan="1" colspan="1">4309</td><td align="left" rowspan="1" colspan="1">55.3</td><td align="left" rowspan="1" colspan="1">4.15</td><td align="left" rowspan="1" colspan="1">(3.74&#x02013;4.62)</td><td align="left" rowspan="1" colspan="1">2.2x10<sup>&#x02212;154</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Former</td><td align="left" rowspan="1" colspan="1">1169</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1923</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2.56</td><td align="left" rowspan="1" colspan="1">(2.25&#x02013;2.90)</td><td align="left" rowspan="1" colspan="1">9.8x10<sup>&#x02212;48</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Current</td><td align="left" rowspan="1" colspan="1">3511</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2279</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.51</td><td align="left" rowspan="1" colspan="1">(5.80&#x02013;7.31)</td><td align="left" rowspan="1" colspan="1">2.4x10<sup>&#x02212;218</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Missing</td><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">107</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Missing</td><td align="left" rowspan="1" colspan="1">387</td><td align="left" rowspan="1" colspan="1">6.5</td><td align="left" rowspan="1" colspan="1">979</td><td align="left" rowspan="1" colspan="1">12.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Drinking status</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Never drinkers</td><td align="left" rowspan="1" colspan="1">904</td><td align="left" rowspan="1" colspan="1">15.2</td><td align="left" rowspan="1" colspan="1">1892</td><td align="left" rowspan="1" colspan="1">24.3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ever drinkers</td><td align="left" rowspan="1" colspan="1">4653</td><td align="left" rowspan="1" colspan="1">78.2</td><td align="left" rowspan="1" colspan="1">4918</td><td align="left" rowspan="1" colspan="1">63.1</td><td align="left" rowspan="1" colspan="1">2.66</td><td align="left" rowspan="1" colspan="1">(2.38&#x02013;2.97)</td><td align="left" rowspan="1" colspan="1">3.0x10<sup>&#x02212;65</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Former</td><td align="left" rowspan="1" colspan="1">758</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">521</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.71</td><td align="left" rowspan="1" colspan="1">(3.13&#x02013;4.41)</td><td align="left" rowspan="1" colspan="1">3.5x10<sup>&#x02212;51</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Current</td><td align="left" rowspan="1" colspan="1">2650</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2588</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.13</td><td align="left" rowspan="1" colspan="1">(2.72&#x02013;3.60)</td><td align="left" rowspan="1" colspan="1">1.9x10<sup>&#x02212;58</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Missing</td><td align="left" rowspan="1" colspan="1">1245</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1809</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Missing</td><td align="left" rowspan="1" colspan="1">390</td><td align="left" rowspan="1" colspan="1">6.6</td><td align="left" rowspan="1" colspan="1">979</td><td align="left" rowspan="1" colspan="1">12.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Site of tumor</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Oral/Oropharynx</td><td align="left" rowspan="1" colspan="1">3105</td><td align="left" rowspan="1" colspan="1">52.2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Larynx/Hypopharynx</td><td align="left" rowspan="1" colspan="1">2182</td><td align="left" rowspan="1" colspan="1">36.7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Esophagus</td><td align="left" rowspan="1" colspan="1">636</td><td align="left" rowspan="1" colspan="1">10.7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Missing</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">0.4</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>OR, CI and p-values represent the risk of UADT in each substrata, adjusted for sex and study specific country of origin.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec004"><title>Genotyping</title><p>The rs10849605 was genotyped using Illumina bead arrays or TaqMan genotyping (C__1244798_10, Applied Biosystems, Carlsbad, CA) at IARC as described elsewhere [<xref rid="pone.0117639.ref003" ref-type="bibr">3</xref>]. The performance of Taqman assays was validated by re-genotyping samples of known genotype (for example HapMap). The genotype distribution was in accordance with that expected by Hardy-Weinberg equilibrium in each country/study. All subsequent genotyping achieved an internal study duplicate concordance rate of &#x0003e;99%.</p></sec><sec id="sec005"><title>The Cancer Genome Atlas data</title><p>We accessed to the Head and Neck Squamous Cell Carcinoma (HNSC), Lung Squamous Cell Carcinoma (LUSC) and Lung Adenocarcinoma (LUAD) components of the TCGA data (TCGA Project Number #3230 and #2731). This data is accessible using the dbGAP via the TGCA (<ext-link ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/tcga/">https://tcga-data.nci.nih.gov/tcga/</ext-link>). Data were downloaded either from <ext-link ext-link-type="uri" xlink:href="https://cghub.ucsc.edu/">https://cghub.ucsc.edu/</ext-link> for exome sequencing or directly from <ext-link ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/tcga/">https://tcga-data.nci.nih.gov/tcga/</ext-link> for the RNA sequencing, methylation and genotype data.</p><sec id="sec006"><title>Exome sequencing</title><p>We accessed TCGA exome sequencing &#x0201c;level 1&#x0201d; (unprocessed) data for 363 HNSC and 459 LUSC TCGA individuals and completed bioinformatics analysis of their sequence data using Picard, GATK, MuTect and Somatic Indel detector (Methods A in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>). Subsequently we used in house bioinformatics pipelines (Methods A in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>) to determine the highest quality variant calls. Somatic point mutations were exonic functional variants defined as either truncating, impacting splicing or missense variants predicted as deleterious by SIFT/POLYPHEN2 [<xref rid="pone.0117639.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0117639.ref017" ref-type="bibr">17</xref>].</p></sec><sec id="sec007"><title>Copy Number Variation</title><p>Samples were hybridized using the Genome-Wide Human SNP Array 6.0 platform at the Genome Analysis Platform of the Broad Institute. We retrieved level 3 TCGA data of 374 HNSC, 464 LUSC and 476 LUAD individuals containing normalized log<sub>2</sub> ratios of the fluorescence intensities between the target sample and a reference sample. We only included in our analysis individuals for whom both tumor and corresponding normal calls were available. For a segment, we considered log<sub>2</sub>(ratio) &#x0003c; -0.5 to be an indication of a loss, and a log<sub>2</sub>(ratio) &#x0003e; 0.5 to indicate a gain. Segments with log<sub>2</sub>(ratio) of between &#x02212;0.5 and 0.5 were not retained as somatic copy number alterations. Annotation was done adding the genes contained in each of the remaining segments using EnsEMBL databases [<xref rid="pone.0117639.ref018" ref-type="bibr">18</xref>].</p></sec><sec id="sec008"><title>RNA sequencing</title><p>RNA sequencing (RNA-seq) TCGA data was retrieved the &#x0201c;level 3&#x0201d; data for 263 HNSC, 223 LUSC and 125 LUAD individuals. Normalization of this data is further detailed within the statistical methods section.</p></sec><sec id="sec009"><title>Methylation</title><p>TCGA methylation data was analysed on the Illumina Infinium HumanMethylation 450K BeadChip assay. We accessed TCGA methylation &#x0201c;level 2&#x0201d; data for 263 HNSC, 223 LUSC and 125 LUAD individuals. We estimated the methylated level of each CpG site by calculating the M-value (log<sub>2</sub>(ratio of methylated and unmethylated probes)) using TCGA level 2 data [<xref rid="pone.0117639.ref019" ref-type="bibr">19</xref>]. Methylation level 2 data is already background-corrected.</p></sec><sec id="sec010"><title>rs10849605 TCGA genotypes</title><p>rs10849605 is located inside the 5&#x02019; region of <italic>RAD52</italic> and was not covered by exome sequencing. Therefore we derived the genotypes for 263 HNSC, 223 LUSC and 125 LUAD individuals using the Affymetrix 6.0 SNP array TCGA data.</p></sec></sec><sec id="sec011"><title>Statistical methods</title><sec id="sec012"><title>Association analysis</title><p>The association between the variants and UADT cancer risk was estimated by odds ratio (ORs) and 95% confidence intervals (CIs) per allele under the log-additive model and genotype derived from multivariate unconditional logistic regression, with sex and study specific country of origin included in the model as covariates (<xref rid="pone.0117639.s002" ref-type="supplementary-material">S1 Table</xref>). Heterogeneity of ORs was assessed using the Cochran&#x02019;s Q test. Statistical analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC, USA).</p><p>To control for potential ethnic heterogeneity between cases and controls, we performed a principal components analysis using the EIGENSTRAT package of the EIGENSOFT 5.0 software [<xref rid="pone.0117639.ref020" ref-type="bibr">20</xref>] using 12,898 markers in low linkage disequilibrium [<xref rid="pone.0117639.ref021" ref-type="bibr">21</xref>]. We used the resulting 12 statistically significant eigen vectors (as defined by the Tracy-Widom statistics) in the sensitivity analysis (Table A in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>).</p></sec><sec id="sec013"><title>eQTL analyses</title><p>The association between rs10849605 germline genotype and <italic>RAD52</italic> tumor expression levels (eQTL) was tested on 263 HNSC, 223 LUSC and 125 LUAD using a linear model. It has been repeatedly observed that tumors acquire somatic alterations that can also influence gene expression, particularly copy number changes and DNA methylation [<xref rid="pone.0117639.ref022" ref-type="bibr">22</xref>&#x02013;<xref rid="pone.0117639.ref024" ref-type="bibr">24</xref>]. Therefore we tested the eQTL effect of rs10849605 on <italic>RAD52</italic> tumor expression using both adjusted and non-adjusted linear models as described in Table B in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>. These statistical analyses were performed using R statistical software (The R Foundation for Statistical Computing, <ext-link ext-link-type="uri" xlink:href="http://www.R-project.org">http://www.R-project.org</ext-link>).</p><p>In order to control for the impact of population heterogeneity, we inferred population structure of the 263 HNSC, 223 LUSC and 125 LUAD TCGA cases with the Structure software [<xref rid="pone.0117639.ref025" ref-type="bibr">25</xref>] using Hapmap release #23 as the reference population [<xref rid="pone.0117639.ref026" ref-type="bibr">26</xref>] and restricted the eQTL analyses to the 215 HNSC, 192 LUSC and 113 LUAD cases predicted to be of European ancestry (CEU&#x0003e;0.8). On these, we further conducted a principal components analysis similar to the GWAS one. The resulting significant eigen vectors (as defined by Tracy-Widom statistics) were used within the eQTL sensitivity analysis (Table C in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>).</p></sec><sec id="sec014"><title>Copy number analysis&#x02014;GISTIC</title><p>We used a publicly available method, called Genomic Identification of Significant Targets in Cancer (GISTIC) [<xref rid="pone.0117639.ref027" ref-type="bibr">27</xref>,<xref rid="pone.0117639.ref028" ref-type="bibr">28</xref>], version 2.0 to find the significantly amplified or deleted regions using TCGA copy number data. The GISTIC algorithm computes p-values for each marker by comparing the score at each locus to a background score distribution generated by random permutation of the marker locations in each sample. Then they correct the p-values for multiple-hypothesis testing using the Benjamini-Hochberg false discovery rate (FDR) method. Therefore the GISTIC scores represent significance levels and are expressed as q-values (significant below 0.25).</p></sec><sec id="sec015"><title>RNA sequencing normalization</title><p>Level 3 RNA sequencing tumor data that we accessed from the TCGA was already normalized to the kilobase per million reads (RPKM) standard which corrects for species length and read depth [<xref rid="pone.0117639.ref029" ref-type="bibr">29</xref>], but not for diversity of the RNA population. To control for this we applied TMM (Trimmed Mean of M-values) normalization [<xref rid="pone.0117639.ref030" ref-type="bibr">30</xref>] to the RPKM data. This possibly involves a loss of statistical efficiency relative to applying TMM to raw data, since the precision weighting in TMM will no longer function. However it should not add any bias and the loss of efficiency will be small if the read density is close to uniform. We used implementations in the EdgeR package of BioConductor [<xref rid="pone.0117639.ref031" ref-type="bibr">31</xref>] and the voom function of the Bioconductor limma package [<xref rid="pone.0117639.ref032" ref-type="bibr">32</xref>]. The normal expression data being available only for a few cases, it was not possible to perform any differential expression analysis.</p></sec></sec></sec><sec sec-type="results" id="sec016"><title>Results</title><sec id="sec017"><title>Germline genetic variation rs10849605 and susceptibility to UADT cancers</title><p>We genotyped rs10849605 in 5,947 UADT cancer cases and 7,789 control individuals from 9 studies. Frequency of the minor allele of rs10849605 varied somewhat by country, with the risk allele (C) being more prevalent in Europe and Latin America countries compared to Asia (51% and 49% versus 40% respectively).</p><p>As observed in squamous cell carcinoma of the lung, the C allele was associated with a modest increase in UADT cancer risk (<xref rid="pone.0117639.g001" ref-type="fig">Fig. 1</xref>, p = 6x10<sup>&#x02212;4</sup>), with the odds ratio (OR) for having one additional risk allele being 1.09 (95%CI: 1.04&#x02013;1.15). The association appeared relatively consistent across geographic region (<xref rid="pone.0117639.g001" ref-type="fig">Fig. 1</xref>), and did not appear sensitive to cryptic population structure within 1,791 cases and 2,531 controls where genome wide data was available to infer genetic ancestry (Table A in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>). The association was also consistent within UADT cancer subsites and consumption of tobacco. However, it was more prominent in those that consumed alcohol compared to non-drinkers (p_het 0.03) (<xref rid="pone.0117639.g001" ref-type="fig">Fig. 1</xref>). There was little evidence to suggest this variant altered consumption patterns of tobacco and alcohol (p = 0.53 and p = 0.40, respectively, pack/years and ethanol/day taken as a continuous variable).</p><fig id="pone.0117639.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0117639.g001</object-id><label>Fig 1</label><caption><title>Association between <italic>RAD52</italic> SNP rs10849605 and UADT cancer risk.</title><p>Squares represent ORs, size of the square represents the inverse of the variance of the log ORs, horizontal lines represent 95% CIs. The solid vertical line indicates OR = 1 and the dashed vertical line the overall OR under the log-additive model. p_het is the p-value for heterogeneity between the different subgroups. I2 is the % of observed variation across subgroups (negative I2 were set to 0).</p></caption><graphic xlink:href="pone.0117639.g001"/></fig></sec><sec id="sec018"><title>Integrated <italic>in-silico</italic> fine mapping of the 12p13.33 locus</title><p>We next undertook <italic>in-silico</italic> analysis of the rs10849605 variant and the <italic>RAD52</italic>/12p13.33 locus in the head and neck and lung cancers genomically characterised by the Cancer Genome Atlas (TCGA).</p></sec><sec id="sec019"><title>Expression quantitative trait locus (eQTL) of rs10849605 in HNSC and LUSC</title><p>rs10849605 is located near the putative promoter 5&#x02019; to the <italic>RAD52</italic> gene, therefore we hypothesized that this, or a correlated proxy variant, might influence <italic>RAD52</italic> gene expression. We performed an expression quantitative trait locus (eQTL) analysis between rs10849605 and <italic>RAD52</italic> expression levels in HNSC (n = 263), using data where both RNAseq of the tumors and genotyping had been carried out by TCGA within the same individuals. rs10849605 was significantly associated with <italic>RAD52</italic> gene expression levels in HNSC (<xref rid="pone.0117639.g002" ref-type="fig">Fig. 2</xref>, n = 263, p = 9x10<sup>&#x02212;4</sup>), suggesting that rs10849605 is a <italic>cis</italic>-eQTL locus for <italic>RAD52</italic>. The C allele of rs10849605, associated with risk of HNSC, was correlated with increased <italic>RAD52</italic> expression levels (<xref rid="pone.0117639.g002" ref-type="fig">Fig. 2</xref>). The association was not sensitive either to adjustment for somatic events (copy number or methylation status which may influence eQTL analysis in tumors [<xref rid="pone.0117639.ref022" ref-type="bibr">22</xref>]), HNSC subtype (larynx/hypopharynx, oral cavity, oropharynx) or population structure (Tables B and C in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>). A comparable effect was observed in LUSC (<xref rid="pone.0117639.g002" ref-type="fig">Fig. 2</xref>, n = 223, p = 8x10<sup>&#x02212;4</sup>) but no clear eQTL association was observed in lung adenocarcinoma (LUAD, <xref rid="pone.0117639.g002" ref-type="fig">Fig. 2</xref>, n = 125, p = 0.75). While statistically significant, the eQTL for rs10849605 accounted for only a small proportion of the variance (approximately 4%) in <italic>RAD52</italic> expression in HNSC and LUSC tumours, an observation in line with the relatively modest genetic risk observed with this variant.</p><fig id="pone.0117639.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0117639.g002</object-id><label>Fig 2</label><caption><title>eQTL analysis.</title><p>Boxplots showing the effect of the genotype for the SNP <italic>RAD52</italic> rs10849605 on <italic>RAD52</italic> tumor expression levels in HNSC, LUSC and LUAD. The risk allele (C) significantly increases <italic>RAD52</italic> expression levels (p = 9x10<sup>&#x02212;4</sup> and 8x10<sup>&#x02212;4</sup> respectively) in both squamous cancers but not in lung adenocarcinoma (p = 0.75). In contrast, there was no evidence for association between rs10849605 and expression levels of other genes in the 12p13.33 region (Table D in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>).</p></caption><graphic xlink:href="pone.0117639.g002"/></fig></sec><sec id="sec020"><title>Somatic alterations at RAD52/12p13.33 in Head and Neck Squamous Cell Carcinoma (HNSC) and LUSC</title><p>Within somatic mutations recalled from paired normal-tumor exome sequencing samples of 305 HNSC and 243 LUSC, <italic>RAD52</italic> was rarely mutated somatically (point mutations and insertions deletions), with only 2 HNSC (0.60% of tumors) and one LUSC (0.40% of tumors) patients harbouring a somatic missense variant, and no somatic insertion or deletion observed.</p><p>By contrast, we analysed the TCGA somatic copy number variation (CNV) data of 374 HNSC, 464 LUSC and 476 LUAD tumors and found that the 12p13.33 locus was a frequent region of copy number gain in HNSC (7.2% of cases) and LUSC (11.2% of cases). Copy number gain of 12p13.33 was observed in a lower proportion of LUAD tumors (3.9% of cases) (<xref rid="pone.0117639.g003" ref-type="fig">Fig. 3</xref>). There was a significant difference in the somatic copy number gain frequencies between SCC and LUAD (p = 3x10<sup>&#x02212;5</sup>). Additionally, we used GISTIC2 statistical program to determine the relative importance of the 12p13.33 gain in comparison with the background rate of copy number changes across the genome [<xref rid="pone.0117639.ref027" ref-type="bibr">27</xref>,<xref rid="pone.0117639.ref028" ref-type="bibr">28</xref>] using the TCGA somatic copy number data. The 12p13.33 region was identified by GISTIC2 as a significant focal amplification in HNSC and LUSC (q-value = 0.075 and 0.007, respectively) but not in LUAD (Figure A in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>).</p><fig id="pone.0117639.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0117639.g003</object-id><label>Fig 3</label><caption><title>Distribution of individuals by <italic>RAD52</italic> expression.</title><p>Individuals were ordered by unsupervised clustering based on <italic>RAD52</italic> expression levels. Heatmap represents the scaled RPKM normalized values with higher expression levels represented in red and lower expression levels in blue. The individuals carrying a copy number gain (log<sub>2</sub>(ratio) &#x0003e; 0.5) of <italic>RAD52</italic> are highlighted in green (light yellow otherwise). <italic>RAD52</italic> gain carriers seem to have the same high expression pattern and cluster together. Particularly in LUAD one of the 3 gain carriers has the highest <italic>RAD52</italic> expression level.</p></caption><graphic xlink:href="pone.0117639.g003"/></fig><p>Presence of somatic copy number gain was also correlated with higher <italic>RAD52</italic> expression levels in both HNSC and LUSC tumors, (p = 6x10<sup>&#x02212;48</sup> and 3x10<sup>&#x02212;29</sup>, respectively) (<xref rid="pone.0117639.g003" ref-type="fig">Fig. 3</xref>), with copy number at this locus accounting for a large proportion of the variance in <italic>RAD52</italic> tumor expression levels (57% in HNSC and 45% in LUSC). As expected, gene expression levels were correlated with copy number for other genes at 12p13.33 (11 out of 26). However, rs10849605 appeared to influence only <italic>RAD52</italic> expression levels (Table D in <xref rid="pone.0117639.s001" ref-type="supplementary-material">S1 File</xref>).</p></sec></sec><sec sec-type="conclusions" id="sec021"><title>Discussion</title><p>Our study has identified rs10849605 to be associated with UADT cancer (p = 6x10<sup>&#x02212;4</sup>). While the modest nature of this association limited our ability to detect inter-substrata heterogeneity, the association was relatively consistent across the diverse etiological settings of Europe, Japan, Latin America and sub-continental Asia (where tobacco chewing is an important UADT cancer risk factor). We note that differing LD patterns, or cryptic population structure where we were unable to control for, could influence these results. Nevertheless, our findings are consistent with the observation that rs10849605 (or variants correlated with it) have also been associated with lung cancer, and particularly lung squamous cell carcinomas. As found in lung cancer [<xref rid="pone.0117639.ref012" ref-type="bibr">12</xref>], the allele C of the susceptibility variant rs10849605 was associated with a modest increased risk of UADT.</p><p>rs10849605 is located at chromosome 12p13.33, a locus that contains the <italic>RAD52</italic> gene. <italic>RAD52</italic> cellular role is DNA double strand break repair via homologous recombination, interacting with multiple DNA repair related genes within this function and therefore a plausible candidate gene to explain this association [<xref rid="pone.0117639.ref033" ref-type="bibr">33</xref>]. Nevertheless, we cannot exclude the possibility of an alternate susceptibility gene to <italic>RAD52</italic> due to linkage disequilibrium. We therefore used an <italic>in-silico</italic> integrative analysis using TCGA expression, genotype and somatic alteration data to fine map this susceptibility locus. 12p13.33 was a region of significant somatic copy number gain in HNSC and LUSC, suggesting that somatic amplification of 12p13.33 is an important molecular event in a subset of tumors. However, the 3MBp amplified region contained multiple genes in addition to <italic>RAD52</italic>. Importantly, rs10849605 was an eQTL in HNSC and LUSC for <italic>RAD52</italic> only, suggesting <italic>RAD52</italic> as the most probable candidate driver gene for both the genetic susceptibility and tumorigenesis at this locus. As an eQTL, the rs10849605 UADT and LUSC risk associated allele (allele C) was correlated with increased <italic>RAD52</italic> expression levels. That higher <italic>RAD52</italic> expression appears involved in both genetic susceptibility and somatic events in UADT and LUSC may indicate that RAD52 activity is enabling tumor cells to have sufficient genome integrity to avoid apoptosis, a trait that may be particularly important within the genotoxic environment created by tobacco smoke and alcohol consumption. Notably, both the eQTL and somatic gains were observed in HNSC and LUSC, but not LUAD, consistent with the lung cancer genetic susceptibility [<xref rid="pone.0117639.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0117639.ref012" ref-type="bibr">12</xref>], reinforcing the importance of this locus in SCC.</p><p>A key role of <italic>RAD52</italic> is to provide cells with a level of redundancy in DNA repair [<xref rid="pone.0117639.ref034" ref-type="bibr">34</xref>]. <italic>RAD52</italic> is therefore particularly important in cells deficient in the BRCA1-PALB2-BRCA2 pathway, providing an alternate mechanism for DNA repair [<xref rid="pone.0117639.ref035" ref-type="bibr">35</xref>,<xref rid="pone.0117639.ref036" ref-type="bibr">36</xref>]. Targeted inhibition of <italic>RAD52</italic> in <italic>BRCA2</italic> deficient cells results in genomic instability and cell growth inhibition, leading to the suggestion of <italic>RAD52</italic> as a potential therapeutic target using synthetic lethality approaches [<xref rid="pone.0117639.ref037" ref-type="bibr">37</xref>]. Our results linking <italic>RAD52</italic> higher gene expression to UADT and LUSC, along with our recent observation that a rare truncating <italic>BRCA2</italic> genetic variant, rs11571833 (K3326X) is associated with a 2.5 fold risk of squamous cell carcinomas of the lung and UADT [<xref rid="pone.0117639.ref038" ref-type="bibr">38</xref>,<xref rid="pone.0117639.ref039" ref-type="bibr">39</xref>], suggests that such targeted therapy approaches may be worth investigating in UADT and LUSC tumors.</p></sec><sec sec-type="supplementary-material" id="sec022"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0117639.s001"><label>S1 File</label><caption><title>Methods A.</title><p><bold>Figure A, Amplification peaks identified across the genome by GISTIC2 in HNSC, LUSC and LUAD</bold>. The Gistic-scores are shown on the top and the q-values on the bottom. The significance line is drawn at q-value = 0.25 and the significantly amplified locus are annotated on the right side of each plot. The 12p13.33 amplified region is framed and indicated with an arrow. <bold>Table A, Population stratification sensitivity analysis.</bold> Model 1 is the original association analysis logistic regression, adjusted for sex and study specific country of origin. Model 2 further adjusts for population stratification including the 12 significant eigen vectors (as defined by Tracy-Widom statistics) as covariates in the logistic regression. <bold>Table B, eQTL analyses using adjusted and non-adjusted linear models to measure the impact of the rs10849605 genotype on <italic>RAD52</italic> tumor expression levels.</bold> The model measures the effect of the protective allele T for rs10849605. Number of individuals taken into account in the model, beta estimates and p-value are given for the three different cancer types and using the following linear models: 1) Non-adjusted, how the genotype influences the gene expression. 2) For HNSC cancer, the subtype (oral cavity, larynx/hypopharynx or oropharynx) is used as the covariate. 3) <italic>RAD52</italic> somatic copy number is used as the covariate. 4) Since we are interested here in the influence of somatic determinants on an increase of expression and because methylation is inversely correlated with expression (hypermethylated sites tend to decrease expression when hypomethylated sites induce increase in expression), we selected 8 of the 24 CpG sites for being hypomethylated (as defined by a negative M-value across all individuals in all our 3 different cancer sites). Out of these 8, only cg15612927 was significantly associated with expression of <italic>RAD52</italic> in all 3 cancers (p-value &#x0003c; 0.05). Therefore tumor methylation levels of cg15612927 was used as the covariate. 5) The initial model is adjusted for all three somatic alterations (subtype for HNSC, somatic copy number and methylation levels). <bold>Table C, eQTL sensitivity analysis.</bold> The linear model measures the effect of rs10849605 genotype on RAD52 tumor expression levels. The first line presents the results on all TCGA cases we accessed. The second line restricts the analysis on TCGA cases predicted to be of European origin. The last line show the results of the same linear model but adjusted for the statistically significant eigen vectors, as defined by Tracy-Widom (5 for HNSC and LUSC, 8 for LUAD). <bold>Table D, 12p13.33 copy number versus expression and eQTL analysis in HNSC and LUSC</bold>. Association analysis between copy number and expression levels for each given gene in the 12p13.33 region (left side of the table, &#x02018;NA&#x02019; if no CNV or expression data available). For the significant associations only, we performed an eQTL analysis to check how rs10849605 genotype influences each given gene expression levels (right side of the table). Significant results are highlighted in green (Bonferroni correction for multiple testing).</p><p>(DOCX)</p></caption><media xlink:href="pone.0117639.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0117639.s002"><label>S1 Table</label><caption><title>Study epidemiological exposures and genetic data.</title><p>(XLSX)</p></caption><media xlink:href="pone.0117639.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors thank all of the participants who took part in this research and the funders and support and technical staff who made this study possible. We also acknowledge and thank The Cancer Genome Atlas initiative whose data contributed heavily to this study.</p></ack><ref-list><title>References</title><ref id="pone.0117639.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Ferlay</surname><given-names>J</given-names></name>, <name><surname>Shin</surname><given-names>HR</given-names></name>, <name><surname>Bray</surname><given-names>F</given-names></name>, <name><surname>Forman</surname><given-names>D</given-names></name>, <name><surname>Mathers</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008</article-title>. <source>Int J Cancer</source><volume>127</volume>: <fpage>2893</fpage>&#x02013;<lpage>2917</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ijc.25516">10.1002/ijc.25516</ext-link></comment>
<?supplied-pmid 21351269?><pub-id pub-id-type="pmid">21351269</pub-id></mixed-citation></ref><ref id="pone.0117639.ref002"><label>2</label><mixed-citation publication-type="book"><name><surname>Stewart</surname><given-names>B</given-names></name>, <name><surname>Kleihues</surname><given-names>P</given-names></name> (<year>2003</year>) <source>World Cancer Report</source>: <publisher-name>IARC Press</publisher-name>.</mixed-citation></ref><ref id="pone.0117639.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>McKay</surname><given-names>JD</given-names></name>, <name><surname>Truong</surname><given-names>T</given-names></name>, <name><surname>Gaborieau</surname><given-names>V</given-names></name>, <name><surname>Chabrier</surname><given-names>A</given-names></name>, <name><surname>Chuang</surname><given-names>SC</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium</article-title>. <source>PLoS Genet</source>
<volume>7</volume>: <fpage>e1001333</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1001333">10.1371/journal.pgen.1001333</ext-link></comment>
<?supplied-pmid 21437268?><pub-id pub-id-type="pmid">21437268</pub-id></mixed-citation></ref><ref id="pone.0117639.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Negri</surname><given-names>E</given-names></name>, <name><surname>Boffetta</surname><given-names>P</given-names></name>, <name><surname>Berthiller</surname><given-names>J</given-names></name>, <name><surname>Castellsague</surname><given-names>X</given-names></name>, <name><surname>Curado</surname><given-names>MP</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium</article-title>. <source>Int J Cancer</source>
<volume>124</volume>: <fpage>394</fpage>&#x02013;<lpage>401</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ijc.23848">10.1002/ijc.23848</ext-link></comment>
<?supplied-pmid 18814262?><pub-id pub-id-type="pmid">18814262</pub-id></mixed-citation></ref><ref id="pone.0117639.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Hoeijmakers</surname><given-names>JH</given-names></name> (<year>2001</year>) <article-title>Genome maintenance mechanisms for preventing cancer</article-title>. <source>Nature</source>
<volume>411</volume>: <fpage>366</fpage>&#x02013;<lpage>374</lpage>. <?supplied-pmid 11357144?><pub-id pub-id-type="pmid">11357144</pub-id></mixed-citation></ref><ref id="pone.0117639.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Scully</surname><given-names>C</given-names></name>, <name><surname>Field</surname><given-names>JK</given-names></name>, <name><surname>Tanzawa</surname><given-names>H</given-names></name> (<year>2000</year>) <article-title>Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control</article-title>. <source>Oral Oncol</source>
<volume>36</volume>: <fpage>256</fpage>&#x02013;<lpage>263</lpage>. <?supplied-pmid 10793327?><pub-id pub-id-type="pmid">10793327</pub-id></mixed-citation></ref><ref id="pone.0117639.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Thacker</surname><given-names>J</given-names></name> (<year>1999</year>) <article-title>The role of homologous recombination processes in the repair of severe forms of DNA damage in mammalian cells</article-title>. <source>Biochimie</source>
<volume>81</volume>: <fpage>77</fpage>&#x02013;<lpage>85</lpage>. <?supplied-pmid 10214913?><pub-id pub-id-type="pmid">10214913</pub-id></mixed-citation></ref><ref id="pone.0117639.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Sung</surname><given-names>P</given-names></name>, <name><surname>Klein</surname><given-names>H</given-names></name> (<year>2006</year>) <article-title>Mechanism of homologous recombination: mediators and helicases take on regulatory functions</article-title>. <source>Nat Rev Mol Cell Biol</source>
<volume>7</volume>: <fpage>739</fpage>&#x02013;<lpage>750</lpage>. <?supplied-pmid 16926856?><pub-id pub-id-type="pmid">16926856</pub-id></mixed-citation></ref><ref id="pone.0117639.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Heyer</surname><given-names>WD</given-names></name> (<year>2011</year>) <article-title>Who's who in human recombination: BRCA2 and RAD52</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>108</volume>: <fpage>441</fpage>&#x02013;<lpage>442</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1016614108">10.1073/pnas.1016614108</ext-link></comment>
<?supplied-pmid 21189297?><pub-id pub-id-type="pmid">21189297</pub-id></mixed-citation></ref><ref id="pone.0117639.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Baumann</surname><given-names>P</given-names></name>, <name><surname>West</surname><given-names>SC</given-names></name> (<year>1998</year>) <article-title>Role of the human RAD51 protein in homologous recombination and double-stranded-break repair</article-title>. <source>Trends Biochem Sci</source>
<volume>23</volume>: <fpage>247</fpage>&#x02013;<lpage>251</lpage>. <?supplied-pmid 9697414?><pub-id pub-id-type="pmid">9697414</pub-id></mixed-citation></ref><ref id="pone.0117639.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>J</given-names></name>, <name><surname>Chatterjee</surname><given-names>N</given-names></name>, <name><surname>Rotunno</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Pesatori</surname><given-names>AC</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma</article-title>. <source>Cancer Discov</source>
<volume>2</volume>: <fpage>131</fpage>&#x02013;<lpage>139</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/2159-8290.CD-11-0246">10.1158/2159-8290.CD-11-0246</ext-link></comment>
<?supplied-pmid 22585858?><pub-id pub-id-type="pmid">22585858</pub-id></mixed-citation></ref><ref id="pone.0117639.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Timofeeva</surname><given-names>MN</given-names></name>, <name><surname>Hung</surname><given-names>RJ</given-names></name>, <name><surname>Rafnar</surname><given-names>T</given-names></name>, <name><surname>Christiani</surname><given-names>DC</given-names></name>, <name><surname>Field</surname><given-names>JK</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls</article-title>. <source>Hum Mol Genet</source>
<volume>21</volume>: <fpage>4980</fpage>&#x02013;<lpage>4995</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/hmg/dds334">10.1093/hmg/dds334</ext-link></comment>
<?supplied-pmid 22899653?><pub-id pub-id-type="pmid">22899653</pub-id></mixed-citation></ref><ref id="pone.0117639.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Yan</surname><given-names>W</given-names></name>, <name><surname>Wistuba</surname><given-names>II</given-names></name>, <name><surname>Emmert-Buck</surname><given-names>MR</given-names></name>, <name><surname>Erickson</surname><given-names>HS</given-names></name> (<year>2011</year>) <article-title>Squamous Cell Carcinoma&#x02014;Similarities and Differences among Anatomical Sites</article-title>. <source>Am J Cancer Res</source>
<volume>1</volume>: <fpage>275</fpage>&#x02013;<lpage>300</lpage>. <?supplied-pmid 21938273?><pub-id pub-id-type="pmid">21938273</pub-id></mixed-citation></ref><ref id="pone.0117639.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Anantharaman</surname><given-names>D</given-names></name>, <name><surname>Chabrier</surname><given-names>A</given-names></name>, <name><surname>Gaborieau</surname><given-names>V</given-names></name>, <name><surname>Franceschi</surname><given-names>S</given-names></name>, <name><surname>Herrero</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India</article-title>. <source>PLoS One</source>
<volume>9</volume>: <fpage>e88240</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0088240">10.1371/journal.pone.0088240</ext-link></comment>
<?supplied-pmid 24505444?><pub-id pub-id-type="pmid">24505444</pub-id></mixed-citation></ref><ref id="pone.0117639.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Oze</surname><given-names>I</given-names></name>, <name><surname>Matsuo</surname><given-names>K</given-names></name>, <name><surname>Hosono</surname><given-names>S</given-names></name>, <name><surname>Ito</surname><given-names>H</given-names></name>, <name><surname>Kawase</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population</article-title>. <source>Cancer Sci</source>
<volume>101</volume>: <fpage>1875</fpage>&#x02013;<lpage>1880</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1349-7006.2010.01599.x">10.1111/j.1349-7006.2010.01599.x</ext-link></comment>
<?supplied-pmid 20518787?><pub-id pub-id-type="pmid">20518787</pub-id></mixed-citation></ref><ref id="pone.0117639.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>PC</given-names></name>, <name><surname>Henikoff</surname><given-names>S</given-names></name> (<year>2003</year>) <article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>. <source>Nucleic Acids Res</source>
<volume>31</volume>: <fpage>3812</fpage>&#x02013;<lpage>3814</lpage>. <?supplied-pmid 12824425?><pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation></ref><ref id="pone.0117639.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Adzhubei</surname><given-names>IA</given-names></name>, <name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Peshkin</surname><given-names>L</given-names></name>, <name><surname>Ramensky</surname><given-names>VE</given-names></name>, <name><surname>Gerasimova</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nat Methods</source>
<volume>7</volume>: <fpage>248</fpage>&#x02013;<lpage>249</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth0410-248">10.1038/nmeth0410-248</ext-link></comment>
<?supplied-pmid 20354512?><pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation></ref><ref id="pone.0117639.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Flicek</surname><given-names>P</given-names></name>, <name><surname>Ahmed</surname><given-names>I</given-names></name>, <name><surname>Amode</surname><given-names>MR</given-names></name>, <name><surname>Barrell</surname><given-names>D</given-names></name>, <name><surname>Beal</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Ensembl 2013</article-title>. <source>Nucleic Acids Res</source>
<volume>41</volume>: <fpage>D48</fpage>&#x02013;<lpage>55</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gks1236">10.1093/nar/gks1236</ext-link></comment>
<?supplied-pmid 23203987?><pub-id pub-id-type="pmid">23203987</pub-id></mixed-citation></ref><ref id="pone.0117639.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Du</surname><given-names>P</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Huang</surname><given-names>CC</given-names></name>, <name><surname>Jafari</surname><given-names>N</given-names></name>, <name><surname>Kibbe</surname><given-names>WA</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis</article-title>. <source>BMC Bioinformatics</source> (<issue>11</issue>): <fpage>587</fpage>.<pub-id pub-id-type="pmid">21118553</pub-id></mixed-citation></ref><ref id="pone.0117639.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Price</surname><given-names>AL</given-names></name>, <name><surname>Patterson</surname><given-names>NJ</given-names></name>, <name><surname>Plenge</surname><given-names>RM</given-names></name>, <name><surname>Weinblatt</surname><given-names>ME</given-names></name>, <name><surname>Shadick</surname><given-names>NA</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>. <source>Nat Genet</source>
<volume>38</volume>: <fpage>904</fpage>&#x02013;<lpage>909</lpage>. <?supplied-pmid 16862161?><pub-id pub-id-type="pmid">16862161</pub-id></mixed-citation></ref><ref id="pone.0117639.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>K</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Wacholder</surname><given-names>S</given-names></name>, <name><surname>Hunter</surname><given-names>DJ</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Population substructure and control selection in genome-wide association studies</article-title>. <source>PLoS One</source>
<volume>3</volume>: <fpage>e2551</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0002551">10.1371/journal.pone.0002551</ext-link></comment>
<?supplied-pmid 18596976?><pub-id pub-id-type="pmid">18596976</pub-id></mixed-citation></ref><ref id="pone.0117639.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Seo</surname><given-names>JH</given-names></name>, <name><surname>Stranger</surname><given-names>B</given-names></name>, <name><surname>McKenna</surname><given-names>A</given-names></name>, <name><surname>Pe'er</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Integrative eQTL-based analyses reveal the biology of breast cancer risk loci</article-title>. <source>Cell</source>
<volume>152</volume>: <fpage>633</fpage>&#x02013;<lpage>641</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2012.12.034">10.1016/j.cell.2012.12.034</ext-link></comment>
<?supplied-pmid 23374354?><pub-id pub-id-type="pmid">23374354</pub-id></mixed-citation></ref><ref id="pone.0117639.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Stranger</surname><given-names>BE</given-names></name>, <name><surname>Forrest</surname><given-names>MS</given-names></name>, <name><surname>Dunning</surname><given-names>M</given-names></name>, <name><surname>Ingle</surname><given-names>CE</given-names></name>, <name><surname>Beazley</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Relative impact of nucleotide and copy number variation on gene expression phenotypes</article-title>. <source>Science</source>
<volume>315</volume>: <fpage>848</fpage>&#x02013;<lpage>853</lpage>. <?supplied-pmid 17289997?><pub-id pub-id-type="pmid">17289997</pub-id></mixed-citation></ref><ref id="pone.0117639.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Portela</surname><given-names>A</given-names></name>, <name><surname>Esteller</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>Epigenetic modifications and human disease</article-title>. <source>Nat Biotechnol</source>
<volume>28</volume>: <fpage>1057</fpage>&#x02013;<lpage>1068</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nbt.1685">10.1038/nbt.1685</ext-link></comment>
<?supplied-pmid 20944598?><pub-id pub-id-type="pmid">20944598</pub-id></mixed-citation></ref><ref id="pone.0117639.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Pritchard</surname><given-names>JK</given-names></name>, <name><surname>Stephens</surname><given-names>M</given-names></name>, <name><surname>Donnelly</surname><given-names>P</given-names></name> (<year>2000</year>) <article-title>Inference of population structure using multilocus genotype data</article-title>. <source>Genetics</source>
<volume>155</volume>: <fpage>945</fpage>&#x02013;<lpage>959</lpage>. <?supplied-pmid 10835412?><pub-id pub-id-type="pmid">10835412</pub-id></mixed-citation></ref><ref id="pone.0117639.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Frazer</surname><given-names>KA</given-names></name>, <name><surname>Ballinger</surname><given-names>DG</given-names></name>, <name><surname>Cox</surname><given-names>DR</given-names></name>, <name><surname>Hinds</surname><given-names>DA</given-names></name>, <name><surname>Stuve</surname><given-names>LL</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>A second generation human haplotype map of over 3.1 million SNPs</article-title>. <source>Nature</source>
<volume>449</volume>: <fpage>851</fpage>&#x02013;<lpage>861</lpage>. <?supplied-pmid 17943122?><pub-id pub-id-type="pmid">17943122</pub-id></mixed-citation></ref><ref id="pone.0117639.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Beroukhim</surname><given-names>R</given-names></name>, <name><surname>Getz</surname><given-names>G</given-names></name>, <name><surname>Nghiemphu</surname><given-names>L</given-names></name>, <name><surname>Barretina</surname><given-names>J</given-names></name>, <name><surname>Hsueh</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>104</volume>: <fpage>20007</fpage>&#x02013;<lpage>20012</lpage>. <?supplied-pmid 18077431?><pub-id pub-id-type="pmid">18077431</pub-id></mixed-citation></ref><ref id="pone.0117639.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Mermel</surname><given-names>CH</given-names></name>, <name><surname>Schumacher</surname><given-names>SE</given-names></name>, <name><surname>Hill</surname><given-names>B</given-names></name>, <name><surname>Meyerson</surname><given-names>ML</given-names></name>, <name><surname>Beroukhim</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers</article-title>. <source>Genome Biol</source>
<volume>12</volume>: <fpage>R41</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/gb-2011-12-4-r41">10.1186/gb-2011-12-4-r41</ext-link></comment>
<?supplied-pmid 21527027?><pub-id pub-id-type="pmid">21527027</pub-id></mixed-citation></ref><ref id="pone.0117639.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Mortazavi</surname><given-names>A</given-names></name>, <name><surname>Williams</surname><given-names>BA</given-names></name>, <name><surname>McCue</surname><given-names>K</given-names></name>, <name><surname>Schaeffer</surname><given-names>L</given-names></name>, <name><surname>Wold</surname><given-names>B</given-names></name> (<year>2008</year>) <article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title>. <source>Nat Methods</source>
<volume>5</volume>: <fpage>621</fpage>&#x02013;<lpage>628</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth.1226">10.1038/nmeth.1226</ext-link></comment>
<?supplied-pmid 18516045?><pub-id pub-id-type="pmid">18516045</pub-id></mixed-citation></ref><ref id="pone.0117639.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name>, <name><surname>Oshlack</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>A scaling normalization method for differential expression analysis of RNA-seq data</article-title>. <source>Genome Biol</source>
<volume>11</volume>: <fpage>R25</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/gb-2010-11-3-r25">10.1186/gb-2010-11-3-r25</ext-link></comment>
<?supplied-pmid 20196867?><pub-id pub-id-type="pmid">20196867</pub-id></mixed-citation></ref><ref id="pone.0117639.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MD</given-names></name>, <name><surname>McCarthy</surname><given-names>DJ</given-names></name>, <name><surname>Smyth</surname><given-names>GK</given-names></name> (<year>2010</year>) <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source>
<volume>26</volume>: <fpage>139</fpage>&#x02013;<lpage>140</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btp616">10.1093/bioinformatics/btp616</ext-link></comment>
<?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation></ref><ref id="pone.0117639.ref032"><label>32</label><mixed-citation publication-type="other">Smyth G (2005) Bioinformatics and Computational Biology Solutions Using R and Bioconductor. In: R Gentleman VC, W. Huber, R. Irizarry, S. Dudoit editor. pp. 397&#x02013;420.</mixed-citation></ref><ref id="pone.0117639.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Symington</surname><given-names>LS</given-names></name> (<year>2002</year>) <article-title>Role of RAD52 epistasis group genes in homologous recombination and double-strand break repair</article-title>. <source>Microbiol Mol Biol Rev</source>
<volume>66</volume>: <fpage>630</fpage>&#x02013;<lpage>670</lpage>, table of contents. <?supplied-pmid 12456786?><pub-id pub-id-type="pmid">12456786</pub-id></mixed-citation></ref><ref id="pone.0117639.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Lok</surname><given-names>BH</given-names></name>, <name><surname>Powell</surname><given-names>SN</given-names></name> (<year>2012</year>) <article-title>Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement</article-title>. <source>Clin Cancer Res</source>
<volume>18</volume>: <fpage>6400</fpage>&#x02013;<lpage>6406</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/1078-0432.CCR-11-3150">10.1158/1078-0432.CCR-11-3150</ext-link></comment>
<?supplied-pmid 23071261?><pub-id pub-id-type="pmid">23071261</pub-id></mixed-citation></ref><ref id="pone.0117639.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Lok</surname><given-names>BH</given-names></name>, <name><surname>Carley</surname><given-names>AC</given-names></name>, <name><surname>Tchang</surname><given-names>B</given-names></name>, <name><surname>Powell</surname><given-names>SN</given-names></name> (<year>2013</year>) <article-title>RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination</article-title>. <source>Oncogene</source>
<volume>32</volume>: <fpage>3552</fpage>&#x02013;<lpage>3558</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/onc.2012.391">10.1038/onc.2012.391</ext-link></comment>
<?supplied-pmid 22964643?><pub-id pub-id-type="pmid">22964643</pub-id></mixed-citation></ref><ref id="pone.0117639.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Feng</surname><given-names>Z</given-names></name>, <name><surname>Scott</surname><given-names>SP</given-names></name>, <name><surname>Bussen</surname><given-names>W</given-names></name>, <name><surname>Sharma</surname><given-names>GG</given-names></name>, <name><surname>Guo</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Rad52 inactivation is synthetically lethal with BRCA2 deficiency</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>108</volume>: <fpage>686</fpage>&#x02013;<lpage>691</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1010959107">10.1073/pnas.1010959107</ext-link></comment>
<?supplied-pmid 21148102?><pub-id pub-id-type="pmid">21148102</pub-id></mixed-citation></ref><ref id="pone.0117639.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Cramer-Morales</surname><given-names>K</given-names></name>, <name><surname>Nieborowska-Skorska</surname><given-names>M</given-names></name>, <name><surname>Scheibner</surname><given-names>K</given-names></name>, <name><surname>Padget</surname><given-names>M</given-names></name>, <name><surname>Irvine</surname><given-names>DA</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile</article-title>. <source>Blood</source>
<volume>122</volume>: <fpage>1293</fpage>&#x02013;<lpage>1304</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2013-05-501072">10.1182/blood-2013-05-501072</ext-link></comment>
<?supplied-pmid 23836560?><pub-id pub-id-type="pmid">23836560</pub-id></mixed-citation></ref><ref id="pone.0117639.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>McKay</surname><given-names>JD</given-names></name>, <name><surname>Rafnar</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Timofeeva</surname><given-names>MN</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer</article-title>. <source>Nat Genet</source>
<volume>46</volume>: <fpage>736</fpage>&#x02013;<lpage>741</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.3002">10.1038/ng.3002</ext-link></comment>
<?supplied-pmid 24880342?><pub-id pub-id-type="pmid">24880342</pub-id></mixed-citation></ref><ref id="pone.0117639.ref039"><label>39</label><mixed-citation publication-type="other">Delahaye-Sourdeix M, Anantharaman D, Timofeeva M, Gaborieau V, Chabrier A, et al. (2015) A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer. J Natl Cancer Inst. (in press)</mixed-citation></ref></ref-list></back></article>